{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:52Z","timestamp":1791158452108,"version":"4.1.0"},"reference-count":321,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Leptin is an adipocyte-secreted hormone that has been proposed to regulate energy homeostasis as well as metabolic, reproductive, neuroendocrine, and immune functions. In the context of open-label uncontrolled studies, leptin administration has demonstrated insulin-sensitizing effects in patients with congenital lipodystrophy associated with relative leptin deficiency. Leptin administration has also been shown to decrease central fat mass and improve insulin sensitivity and fasting insulin and glucose levels in HIV-infected patients with highly active antiretroviral therapy (HAART)-induced lipodystrophy, insulin resistance, and leptin deficiency. On the contrary, the effects of leptin treatment in leptin-replete or hyperleptinemic obese individuals with glucose intolerance and diabetes mellitus have been minimal or null, presumably due to leptin tolerance or resistance that impairs leptin action. Similarly, experimental evidence suggests a null or a possibly adverse role of leptin treatment in nonlipodystrophic patients with nonalcoholic fatty liver disease. In this review, we present a description of leptin biology and signaling; we summarize leptin's contribution to glucose metabolism in animals and humans in vitro, ex vivo, and in vivo; and we provide insights into the emerging clinical applications and therapeutic uses of leptin in humans with lipodystrophy and\/or diabetes.<\/jats:p>","DOI":"10.1210\/er.2012-1053","type":"journal-article","created":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T17:25:46Z","timestamp":1369934746000},"page":"377-412","source":"Crossref","is-referenced-by-count":226,"title":["Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals"],"prefix":"10.1210","volume":"34","author":[{"given":"Hyun-Seuk","family":"Moon","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism (H.-S.M., S.-Y.K., O.-P.H., F.M., J.P., C.S.M.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dalamaga","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry (M.D.), Attikon General University Hospital, Athens University Medical School, Athens 15784, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Yong","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism (H.-S.M., S.-Y.K., O.-P.H., F.M., J.P., C.S.M.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215;"},{"name":"Division of Endocrinology and Metabolism (S.-Y.K.), School of Medicine, Chosun University, Gwang-Ju 501-717, South Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[{"name":"Second Medical Clinic (S.A.P.), Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki 11527, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole-Petter","family":"Hamnvik","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism (H.-S.M., S.-Y.K., O.-P.H., F.M., J.P., C.S.M.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215;"},{"name":"Division of Endocrinology, Diabetes, and Hypertension (O.-P.H.), Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faidon","family":"Magkos","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism (H.-S.M., S.-Y.K., O.-P.H., F.M., J.P., C.S.M.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Paruthi","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism (H.-S.M., S.-Y.K., O.-P.H., F.M., J.P., C.S.M.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism (H.-S.M., S.-Y.K., O.-P.H., F.M., J.P., C.S.M.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215;"},{"name":"Section of Endocrinology (C.S.M.), Boston VA Healthcare System, Harvard Medical School, Boston, Massachusetts 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071611542428900_B1","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice","volume":"269","author":"Pelleymounter","year":"1995","journal-title":"Science"},{"key":"2020071611542428900_B3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.yfrne.2010.06.002","article-title":"Leptin in human physiology and therapeutics","volume":"31","author":"Dardeno","year":"2010","journal-title":"Front Neuroendocrinol"},{"key":"2020071611542428900_B4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(05)66830-4","article-title":"Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa","volume":"366","author":"Chan","year":"2005","journal-title":"Lancet"},{"key":"2020071611542428900_B5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.7624777","article-title":"Weight-reducing effects of the plasma protein encoded by the obese gene","volume":"269","author":"Halaas","year":"1995","journal-title":"Science"},{"key":"2020071611542428900_B6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1126\/science.7624778","article-title":"Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks","volume":"269","author":"Campfield","year":"1995","journal-title":"Science"},{"key":"2020071611542428900_B7","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1210\/jc.2004-1823","article-title":"Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-\u03b1 receptor levels in humans with relative leptin deficiency","volume":"90","author":"Chan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/diab.45.11.1638","article-title":"Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity","volume":"45","author":"Houseknecht","year":"1996","journal-title":"Diabetes"},{"key":"2020071611542428900_B9","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2337\/diabetes.51.5.1337","article-title":"Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity","volume":"51","author":"Pierroz","year":"2002","journal-title":"Diabetes"},{"key":"2020071611542428900_B10","doi-asserted-by":"crossref","first-page":"991S","DOI":"10.3945\/ajcn.2008.26788E","article-title":"Leptin in humans: lessons from translational research","volume":"89","author":"Bl\u00fcher","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"2020071611542428900_B11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpendmet0196","article-title":"Drug insight: the role of leptin in human physiology and pathophysiology: emerging clinical applications","volume":"2","author":"Brennan","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2020071611542428900_B12","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1152\/ajpendo.00146.2011","article-title":"Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women","volume":"301","author":"Brinkoetter","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611542428900_B13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann Intern Med"},{"key":"2020071611542428900_B14","doi-asserted-by":"crossref","first-page":"2469S","DOI":"10.1093\/jn\/134.9.2469S","article-title":"The role of leptin in regulating neuroendocrine function in humans","volume":"134","author":"Bluher","year":"2004","journal-title":"J Nutr"},{"key":"2020071611542428900_B15","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.2337\/diabetes.51.7.2105","article-title":"Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans","volume":"51","author":"Chan","year":"2002","journal-title":"Diabetes"},{"key":"2020071611542428900_B16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1012947113197","article-title":"Leptin and the hypothalamic-pituitary regulation of the gonadotropin-gonadal axis","volume":"4","author":"Chan","year":"2001","journal-title":"Pituitary"},{"key":"2020071611542428900_B17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1749-6632.2000.tb06228.x","article-title":"Role of leptin in reproduction","volume":"900","author":"Mantzoros","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"2020071611542428900_B18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-130-8-199904200-00014","article-title":"The role of leptin in human obesity and disease: a review of current evidence","volume":"130","author":"Mantzoros","year":"1999","journal-title":"Ann Intern Med"},{"key":"2020071611542428900_B19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-011-2332-0","article-title":"Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, C(2)C (12) muscle and AML12 liver cell lines","volume":"55","author":"Moon","year":"2012","journal-title":"Diabetologia"},{"key":"2020071611542428900_B20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/db10-1791","article-title":"Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance","volume":"60","author":"Moon","year":"2011","journal-title":"Diabetes"},{"key":"2020071611542428900_B21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc10-0518","article-title":"Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans","volume":"34","author":"Moon","year":"2011","journal-title":"Diabetes Care"},{"key":"2020071611542428900_B22","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"2020071611542428900_B23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071611542428900_B24","first-page":"229","article-title":"Leptin and obesity","volume":"100","author":"de Luis","year":"2009","journal-title":"Minerva Medica"},{"key":"2020071611542428900_B25","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/ijo.2008.245","article-title":"Molecular physiology of weight regulation in mice and humans","volume":"32","author":"Leibel","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"2020071611542428900_B26","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/sj.ijo.0801385","article-title":"A Leptin plasma concentrations are dependent on body fat distribution in obese patients","volume":"24","author":"Minocci","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071611542428900_B27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","article-title":"Lipotoxic diseases","volume":"53","author":"Unger","year":"2002","journal-title":"Annu Rev Med"},{"key":"2020071611542428900_B28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.chc.2008.07.002","article-title":"Leptin-mediated neuroendocrine alterations in anorexia nervosa: somatic and behavioral implications","volume":"18","author":"M\u00fcller","year":"2009","journal-title":"Child Adolesc Psychiatr Clin North Am"},{"key":"2020071611542428900_B29","doi-asserted-by":"crossref","first-page":"208S","DOI":"10.1038\/oby.2006.310","article-title":"Leptin receptor signaling and action in the central nervous system","volume":"14","author":"Leshan","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"2020071611542428900_B30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.physbeh.2006.05.038","article-title":"The role of leptin in leptin resistance and obesity","volume":"88","author":"Zhang","year":"2006","journal-title":"Physiol Behav"},{"key":"2020071611542428900_B31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tips.2006.02.009","article-title":"Techniques: new pharmacological perspectives for the leptin receptor","volume":"27","author":"Peelman","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"2020071611542428900_B32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1196\/annals.1418.023","article-title":"Perinatal maternal fat intake affects metabolism and hippocampal function in the offspring: a potential role for leptin","volume":"1144","author":"Walker","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"2020071611542428900_B33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ajmg.a.31099","article-title":"Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling","volume":"140","author":"Cohen","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"Pt 1","key":"2020071611542428900_B34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BJ20051578","article-title":"Intracellular signalling pathways activated by leptin","volume":"393","author":"Fr\u00fchbeck","year":"2006","journal-title":"Biochem J"},{"key":"2020071611542428900_B35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.1.06227","article-title":"Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies","volume":"186","author":"Lappas","year":"2005","journal-title":"J Endocrinol"},{"key":"2020071611542428900_B36","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1371\/journal.pone.0022978","article-title":"Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation","volume":"6","author":"Mencarelli","year":"2011","journal-title":"PLoS One"},{"key":"2020071611542428900_B37","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1073\/pnas.182420899","article-title":"PPAR\u03b1 is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B38","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.4049\/jimmunol.176.12.7745","article-title":"Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice","volume":"176","author":"Papathanassoglou","year":"2006","journal-title":"J Immunol"},{"key":"2020071611542428900_B39","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/en.2009-0462","article-title":"Rosiglitazone increases the expression of peroxisome proliferator-activated receptor-\u03b3 target genes in adipose tissue, liver, and skeletal muscle in the sheep fetus in late gestation","volume":"150","author":"Muhlhausler","year":"2009","journal-title":"Endocrinology"},{"key":"2020071611542428900_B40","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1210\/en.2008-0498","article-title":"Leptin regulates peripheral lipid metabolism primarily through central effects on food intake","volume":"149","author":"Prieur","year":"2008","journal-title":"Endocrinology"},{"key":"2020071611542428900_B41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09513590500099305","article-title":"Progesterone and human placental lactogen inhibit leptin secretion on cultured trophoblast cells from human placentas at term","volume":"21","author":"Coya","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"2020071611542428900_B42","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.2337\/diabetes.53.2007.S152","article-title":"Leptin effects on pancreatic \u03b2-cell gene expression and function","volume":"53","author":"Seufert","year":"2004","journal-title":"Diabetes"},{"key":"2020071611542428900_B43","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1210\/en.2007-0933","article-title":"Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue","volume":"148","author":"Gallardo","year":"2007","journal-title":"Endocrinology"},{"key":"2020071611542428900_B44","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbadis.2009.09.001","article-title":"Failure of the feeding response to fasting in carnitine-deficient juvenile visceral steatosis (JVS) mice: involvement of defective acyl-ghrelin secretion and enhanced corticotropin-releasing factor signaling in the hypothalamus","volume":"1792","author":"Sakoguchi","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2020071611542428900_B45","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1194\/jlr.M001602","article-title":"FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa\/fa) obese rats","volume":"51","author":"Cipriani","year":"2010","journal-title":"J Lipids Res"},{"key":"2020071611542428900_B46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2337\/diabetes.48.2.279","article-title":"Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation","volume":"48","author":"Uotani","year":"1999","journal-title":"Diabetes"},{"key":"2020071611542428900_B47","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1073\/pnas.91.23.10878","article-title":"\u03b2-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-\u03b2-cell relationships","volume":"91","author":"Lee","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B48","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1096\/fj.00-0590","article-title":"Diseases of liporegulation: new perspective on obesity and related disorders","volume":"15","author":"Unger","year":"2001","journal-title":"FASEB J"},{"key":"2020071611542428900_B49","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1073\/pnas.96.5.2327","article-title":"Regulation of fatty acid homeostasis in cells: novel role of leptin","volume":"96","author":"Unger","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B50","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1152\/ajpendo.1997.273.4.E708","article-title":"Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity","volume":"273","author":"Koyama","year":"1997","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611542428900_B51","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1073\/pnas.95.5.2498","article-title":"Fatty acid-induced \u03b2-cell apoptosis: a link between obesity and diabetes","volume":"95","author":"Shimabukuro","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B52","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1073\/pnas.95.16.9558","article-title":"Protection against lipoapoptosis of \u03b2-cells through leptin-dependent maintenance of Bcl-2 expression","volume":"95","author":"Shimabukuro","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B53","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1074\/jbc.273.6.3547","article-title":"Troglitazone lowers islet fat and restores \u03b2 cell function of Zucker diabetic fatty rats","volume":"273","author":"Shimabukuro","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071611542428900_B54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbalip.2009.10.006","article-title":"Lipid homeostasis, lipotoxicity and the metabolic syndrome","volume":"1801","author":"Unger","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2020071611542428900_B55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tem.2010.01.009","article-title":"Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity","volume":"21","author":"Unger","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"2020071611542428900_B56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00273856","article-title":"Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes","volume":"28","author":"Unger","year":"1985","journal-title":"Diabetologia"},{"key":"2020071611542428900_B57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00592-008-0067-2","article-title":"The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease","volume":"46","author":"Nar","year":"2009","journal-title":"Acta Diabetol"},{"key":"2020071611542428900_B58","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1073\/pnas.0909422107","article-title":"Leptin therapy in insulin-deficient type I diabetes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B59","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/en.2010-0102","article-title":"Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic \u03b2-cell leptin signaling","volume":"151","author":"Gray","year":"2010","journal-title":"Endocrinology"},{"key":"2020071611542428900_B60","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1096\/fj.07-101824","article-title":"Glucose and leptin induce apoptosis in human \u03b2-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases","volume":"22","author":"Maedler","year":"2008","journal-title":"FASEB J"},{"key":"2020071611542428900_B61","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00774-009-0082-6","article-title":"Relationship between bone mineral density, leptin and insulin concentration in Brazilian obese adolescents","volume":"27","author":"do Prado","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"2020071611542428900_B62","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1515\/jpem.2010.077","article-title":"Serum levels of adiponectin and leptin in children born small for gestational age: relation to insulin sensitivity parameters","volume":"23","author":"Miras","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071611542428900_B63","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.20672","article-title":"Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy","volume":"41","author":"Javor","year":"2005","journal-title":"Hepatology"},{"key":"2020071611542428900_B64","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1172\/JCI59816","article-title":"Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice","volume":"122","author":"Berglund","year":"2012","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B65","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrd3757","article-title":"Leptin revisited: its mechanism of action and potential for treating diabetes","volume":"11","author":"Coppari","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"2020071611542428900_B66","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1073\/pnas.1006639107","article-title":"Paracrinology of islets and the paracrinopathy of diabetes","volume":"107","author":"Unger","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B67","doi-asserted-by":"crossref","first-page":"14070","DOI":"10.1073\/pnas.0806993105","article-title":"Making insulin-deficient type 1 diabetic rodents thrive without insulin","volume":"105","author":"Yu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B68","doi-asserted-by":"crossref","first-page":"17391","DOI":"10.1073\/pnas.1008025107","article-title":"Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice","volume":"107","author":"Fujikawa","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B69","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.peptides.2009.07.021","article-title":"Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation","volume":"30","author":"Kalra","year":"2009","journal-title":"Peptides"},{"key":"2020071611542428900_B70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI60016","article-title":"Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover","volume":"122","author":"Unger","year":"2012","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B71","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.4049\/jimmunol.174.6.3137","article-title":"Leptin in immunology","volume":"15;174","author":"Matarese","year":"2005","journal-title":"J Immunol"},{"key":"2020071611542428900_B72","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.biochi.2012.05.018","article-title":"Immunological functions of leptin and adiponectin","volume":"94","author":"Carbone","year":"2012","journal-title":"Biochimie"},{"key":"2020071611542428900_B73","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1523\/JNEUROSCI.6562-10.2011","article-title":"Role of central leptin signaling in the starvation-induced alteration of B-cell development","volume":"31","author":"Tanaka","year":"2011","journal-title":"J Neurosci"},{"key":"2020071611542428900_B74","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"key":"2020071611542428900_B75","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0006-291X(02)02462-2","article-title":"Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation","volume":"298","author":"Tian","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071611542428900_B76","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2007.01.011","article-title":"A key role of leptin in the control of regulatory T cell proliferation","volume":"26","author":"De Rosa","year":"2007","journal-title":"Immunity"},{"key":"2020071611542428900_B77","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.4049\/jimmunol.168.8.4018","article-title":"Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia","volume":"168","author":"Mancuso","year":"2002","journal-title":"J Immunol"},{"key":"2020071611542428900_B78","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.84.10.5999","article-title":"Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects","volume":"84","author":"Ozata","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B79","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jn\/137.5.1236","article-title":"Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus","volume":"137","author":"Smith","year":"2007","journal-title":"J Nutr"},{"key":"2020071611542428900_B80","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.amjsurg.2011.06.020","article-title":"The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase\/signal transducer and activator of transcription activation","volume":"202","author":"McCormack","year":"2011","journal-title":"Am J Surg"},{"key":"2020071611542428900_B81","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.yhbeh.2011.07.012","article-title":"Effects of androgen and leptin on behavioral and cellular responses in female rats","volume":"60","author":"Feng","year":"2011","journal-title":"Horm Behav"},{"key":"2020071611542428900_B82","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.3748\/wjg.v17.i34.3922","article-title":"Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3","volume":"17","author":"Gu","year":"2011","journal-title":"World J Gastroenterol"},{"key":"2020071611542428900_B83","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1947601910383417","article-title":"Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer","volume":"1","author":"Okitsu","year":"2010","journal-title":"Genes Cancer"},{"key":"2020071611542428900_B84","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1177\/147323001003800512","article-title":"Inhibition of the signal transducers and activators of transcription (STAT) 3 signalling pathway by AG490 in laryngeal carcinoma cells","volume":"38","author":"Zhang","year":"2010","journal-title":"J Int Med Res"},{"key":"2020071611542428900_B85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.20100799","article-title":"Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells","volume":"208","author":"Saito","year":"2011","journal-title":"J Exp Med"},{"key":"2020071611542428900_B86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2011.01.001","article-title":"Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES)","volume":"139","author":"Heimall","year":"2011","journal-title":"Clin Immunol"},{"key":"2020071611542428900_B87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nm1775","article-title":"Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms","volume":"14","author":"Buettner","year":"2008","journal-title":"Nat Med"},{"key":"2020071611542428900_B88","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1073\/pnas.0303992101","article-title":"Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation","volume":"101","author":"Gao","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B89","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1074\/jbc.M109.056762","article-title":"AMPK \u03b21 deletion reduces appetite, preventing obesity and hepatic insulin resistance","volume":"285","author":"Dzamko","year":"2010","journal-title":"J Biol Chem"},{"key":"2020071611542428900_B90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1748-1716.2009.01969.x","article-title":"AMPK-dependent hormonal regulation of whole-body energy metabolism","volume":"196","author":"Dzamko","year":"2009","journal-title":"Acta Physiol (Oxf)"},{"key":"2020071611542428900_B91","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1211\/jpp.61.10.0010","article-title":"Comparative study between the effect of the peroxisome proliferator activated receptor-\u03b1 ligands fenofibrate and n-3 polyunsaturated fatty acids on activation of 5\u2032-AMP-activated protein kinase-\u03b11 in high-fat fed rats","volume":"61","author":"Motawi","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"2020071611542428900_B92","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2009.07.130","article-title":"A role for AMPK in the inhibition of glucose-6-phosphate dehydrogenase by polyunsaturated fatty acids","volume":"388","author":"Kohan","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071611542428900_B93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1677\/JME-09-0063","article-title":"AMPK as a mediator of hormonal signalling","volume":"44","author":"Lim","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"2020071611542428900_B94","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1128\/MCB.02222-06","article-title":"Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor \u03b1 gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the \u03b12 form of AMP-activated protein kinase","volume":"27","author":"Suzuki","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2020071611542428900_B95","doi-asserted-by":"crossref","first-page":"E356","DOI":"10.1152\/ajpendo.90256.2008","article-title":"Induction of muscle thermogenesis by high-fat diet in mice: association with obesity-resistance","volume":"295","author":"Kus","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611542428900_B96","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cmet.2007.04.004","article-title":"Central melanocortin signaling restores skeletal muscle AMP-activated protein kinase phosphorylation in mice fed a high-fat diet","volume":"5","author":"Tanaka","year":"2007","journal-title":"Cell Metab"},{"key":"2020071611542428900_B97","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4161\/cc.10.20.17886","article-title":"Insulin resistance due to nutrient excess: Is it a consequence of AMPK downregulation?","volume":"10","author":"Saha","year":"2011","journal-title":"Cell Cycle"},{"key":"2020071611542428900_B98","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1758-5996-3-16","article-title":"Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation","volume":"3","author":"Grisouard","year":"2011","journal-title":"Diabetol Metab Syndr"},{"key":"2020071611542428900_B99","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/415339a","article-title":"Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase","volume":"415","author":"Minokoshi","year":"2002","journal-title":"Nature"},{"key":"2020071611542428900_B100","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.lfs.2011.03.015","article-title":"Long-term high-fat diet-induced obesity decreases the cardiac leptin receptor without apparent lipotoxicity","volume":"88","author":"Nascimento","year":"2011","journal-title":"Life Sci"},{"key":"2020071611542428900_B101","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12154-008-0008-0","article-title":"Insights into the PI3-K-PKB-mTOR signalling pathway from small molecules","volume":"1","author":"Gunn","year":"2008","journal-title":"J Chem Biol"},{"key":"2020071611542428900_B102","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10059-010-0003-5","article-title":"Mycobacterium tuberculosis-induced expression of leukotactin-1 is mediated by the PI3-K\/PDK1\/Akt signaling pathway","volume":"29","author":"Cho","year":"2010","journal-title":"Mol Cells"},{"key":"2020071611542428900_B103","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/IGC.0b013e3181a83749","article-title":"Epidermal growth factor receptor regulates MT1-MMP and MMP-2 synthesis in SiHa cells via both PI3-K\/AKT and MAPK\/ERK pathways","volume":"19","author":"Zhang","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"2020071611542428900_B104","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.metabol.2009.09.007","article-title":"Augmentation of insulin secretion by leucine supplementation in malnourished rats: possible involvement of the phosphatidylinositol 3-phosphate kinase\/mammalian target protein of rapamycin pathway","volume":"59","author":"Filiputti","year":"2010","journal-title":"Metab Clin Exp"},{"key":"2020071611542428900_B105","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.neuint.2011.07.005","article-title":"PI3-K\/Akt and ERK pathways activated by VEGF play opposite roles in MPP(+)-induced neuronal apoptosis","volume":"59","author":"Cui","year":"2011","journal-title":"Neurochem Int"},{"key":"2020071611542428900_B106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-2187-2-9","article-title":"PI3 K\/Akt\/mTOR-mediated translational control regulates proliferation and differentiation of lineage-restricted RoSH stem cell lines","volume":"2","author":"Que","year":"2007","journal-title":"J Mol Signal"},{"key":"2020071611542428900_B107","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ejcb.2011.03.005","article-title":"Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the av?3\/PI3K\/AKT\/eNOS\/NO signaling pathway in glioma cells","volume":"90","author":"Wang","year":"2011","journal-title":"Eur J Cell Biol"},{"key":"2020071611542428900_B108","first-page":"1054","article-title":"Leptin inhibits the proliferation of vascular smooth muscle cells induced by angiotensin II through nitric oxide-dependent mechanisms","author":"Rodr\u00edguez","year":"2010","journal-title":"Mediators Inflamm"},{"key":"2020071611542428900_B109","doi-asserted-by":"crossref","first-page":"E586","DOI":"10.1210\/jc.2010-1408","article-title":"Insulin- and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K\/Akt\/mTOR signaling cascade","volume":"96","author":"Rodr\u00edguez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B110","first-page":"1265","article-title":"Leptin enhances migration of human papillary thyroid cancer cells through the PI3K\/AKT and MEK\/ERK signaling pathways","volume":"26","author":"Cheng","year":"2011","journal-title":"Oncol Rep"},{"key":"2020071611542428900_B111","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/pros.21309","article-title":"Leptin signaling and apoptotic effects in human prostate cancer cell lines","volume":"71","author":"Samuel-Mendelsohn","year":"2011","journal-title":"Prostate"},{"key":"2020071611542428900_B112","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1210\/en.2004-1396","article-title":"Moderate caloric restriction, but not physiological hyperleptinemia per se, enhances mitochondrial oxidative capacity in rat liver and skeletal muscle\u2013tissue-specific impact on tissue triglyceride content and AKT activation","volume":"146","author":"Barazzoni","year":"2005","journal-title":"Endocrinology"},{"key":"2020071611542428900_B113","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1007\/s00125-009-1462-0","article-title":"Leptin prevents the metabolic effects of adiponectin in L6 myotubes","volume":"52","author":"Fang","year":"2009","journal-title":"Diabetologia"},{"key":"2020071611542428900_B114","doi-asserted-by":"crossref","first-page":"11582","DOI":"10.1523\/JNEUROSCI.5712-08.2009","article-title":"Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity","volume":"29","author":"Ernst","year":"2009","journal-title":"J Neurosci"},{"key":"2020071611542428900_B115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1530\/EJE-11-0252","article-title":"Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet","volume":"165","author":"Shetty","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2020071611542428900_B116","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2202-5-54","article-title":"Leptin and insulin stimulation of signalling pathways in arcuate nucleus neurones: PI3K dependent actin reorganization and KATP channel activation","volume":"5","author":"Mirshamsi","year":"2004","journal-title":"BMC Neurosci"},{"key":"2020071611542428900_B117","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cmet.2010.03.002","article-title":"Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility","volume":"11","author":"Hill","year":"2010","journal-title":"Cell Metab"},{"key":"2020071611542428900_B118","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cmet.2009.09.008","article-title":"Dominant role of the p110\u03b2 isoform of PI3K over p110\u03b1 in energy homeostasis regulation by POMC and AgRP neurons","volume":"10","author":"Al-Qassab","year":"2009","journal-title":"Cell Metab"},{"key":"2020071611542428900_B119","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1507\/endocrj.K10E-320","article-title":"Roles of FoxO1 and Sirt1 in the central regulation of food intake","volume":"57","author":"Sasaki","year":"2010","journal-title":"Endocr J"},{"key":"2020071611542428900_B120","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1172\/JCI46243","article-title":"Hepatic Sirt1 deficiency in mice impairs mTorc2\/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance","volume":"121","author":"Wang","year":"2011","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B121","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2337\/db10-1194","article-title":"Rictor\/mTORC2 is essential for maintaining a balance between \u03b2-cell proliferation and cell size","volume":"60","author":"Gu","year":"2011","journal-title":"Diabetes"},{"key":"2020071611542428900_B122","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1210\/en.2011-1229","article-title":"Insulin\/IGF-I regulation of necdin and brown adipocyte differentiation via CREB- and FoxO1-associated pathways","volume":"152","author":"Cypess","year":"2011","journal-title":"Endocrinology"},{"key":"2020071611542428900_B123","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.febslet.2008.03.037","article-title":"AdipoR1 mediates the anorexigenic and insulin\/leptin-like actions of adiponectin in the hypothalamus","volume":"582","author":"Coope","year":"2008","journal-title":"FEBS Lett"},{"key":"2020071611542428900_B124","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/en.2009-0997","article-title":"Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1","volume":"151","author":"Reiter","year":"2010","journal-title":"Endocrinology"},{"key":"2020071611542428900_B125","doi-asserted-by":"crossref","first-page":"E787","DOI":"10.1152\/ajpendo.00512.2009","article-title":"PDK-1\/FoxO1 pathway in POMC neurons regulates Pomc expression and food intake","volume":"298","author":"Iskandar","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611542428900_B126","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1210\/en.2009-1319","article-title":"Induction of hypothalamic Sirt1 leads to cessation of feeding via agouti-related peptide","volume":"151","author":"Sasaki","year":"2010","journal-title":"Endocrinology"},{"key":"2020071611542428900_B127","doi-asserted-by":"crossref","first-page":"e8322","DOI":"10.1371\/journal.pone.0008322","article-title":"Hypothalamic Sirt1 regulates food intake in a rodent model system","volume":"4","author":"Cakir","year":"2009","journal-title":"PLoS One"},{"key":"2020071611542428900_B128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2249.2007.03563.x","article-title":"Leptin promotes cell survival and activates Jurkat T lymphocytes by stimulation of mitogen-activated protein kinase","volume":"151","author":"Fern\u00e1ndez-Riejos","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2020071611542428900_B129","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jcp.21883","article-title":"Leptin attenuates hypoxia\/reoxygenation-induced activation of the intrinsic pathway of apoptosis in rat H9c2 cells","volume":"221","author":"Shin","year":"2009","journal-title":"J Cell Physiol"},{"key":"2020071611542428900_B130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0167-4838(00)00257-0","article-title":"A model of activation of the protein tyrosine phosphatase SHP-2 by the human leptin receptor","volume":"1545","author":"L\u00f6thgren","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"2020071611542428900_B131","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jcb.22582","article-title":"Integrin \u03b24 attenuates SHP-2 and MAPK signaling and reduces human lung endothelial inflammatory responses","volume":"110","author":"Chen","year":"2010","journal-title":"J Cell Biochem"},{"key":"2020071611542428900_B132","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1074\/jbc.M109.066480","article-title":"Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells","volume":"285","author":"Carver","year":"2010","journal-title":"J Biol Chem"},{"key":"2020071611542428900_B133","doi-asserted-by":"crossref","first-page":"29374","DOI":"10.1074\/jbc.M313955200","article-title":"The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling","volume":"279","author":"Kolli","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071611542428900_B134","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1074\/jbc.M007439200","article-title":"Divergent roles of SHP-2 in ERK activation by leptin receptors","volume":"276","author":"Bj\u00f8rbaek","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071611542428900_B135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1471-4159.2004.02514.x","article-title":"In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus","volume":"90","author":"Anh\u00ea","year":"2004","journal-title":"J Neurochem"},{"key":"2020071611542428900_B136","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI39620","article-title":"PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice","volume":"120","author":"Banno","year":"2010","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B137","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/MCB.01307-09","article-title":"Signaling through Tyr985 of leptin receptor as an age\/diet-dependent switch in the regulation of energy balance","volume":"30","author":"You","year":"2010","journal-title":"Mol Cell Biol"},{"key":"2020071611542428900_B138","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/1471-2164-12-520","article-title":"Proteomic and biochemical analyses reveal the activation of unfolded protein response, ERK-1\/2 and ribosomal protein S6 signaling in experimental autoimmune myocarditis rat model","volume":"12","author":"Chung","year":"2011","journal-title":"BMC Genomics"},{"key":"2020071611542428900_B139","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12020-007-9025-y","article-title":"Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK\/STAT and MAPK pathways","volume":"32","author":"Ben-Eliezer","year":"2007","journal-title":"Endocrine"},{"key":"2020071611542428900_B140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.freeradbiomed.2006.10.049","article-title":"Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-\u03baB signaling","volume":"42","author":"Katiyar","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"2020071611542428900_B141","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.lfs.2005.04.004","article-title":"Leptin enhances TNF-\u03b1 production via p38 and JNK MAPK in LPS-stimulated Kupffer cells","volume":"77","author":"Shen","year":"2005","journal-title":"Life Sci"},{"key":"2020071611542428900_B142","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0083-6729(08)00610-9","article-title":"How insulin regulates glucose transport in adipocytes","volume":"80","author":"Muretta","year":"2009","journal-title":"Vitam Horm"},{"key":"2020071611542428900_B143","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/dmrr.1250","article-title":"Insulin as a key autoantigen in the development of type 1 diabetes","volume":"27","author":"Nakayama","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"2020071611542428900_B144","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/157339907781368986","article-title":"Physical activity, insulin action, and diabetes prevention and control","volume":"3","author":"Colberg","year":"2007","journal-title":"Curr Diabetes Rev"},{"key":"2020071611542428900_B145","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s00125-007-0601-8","article-title":"Regulation of pancreatic islet cell survival and replication by \u03b3-aminobutyric acid","volume":"50","author":"Ligon","year":"2007","journal-title":"Diabetologia"},{"key":"2020071611542428900_B146","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1172\/JCI58056","article-title":"Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice","volume":"121","author":"Wei","year":"2011","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B147","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1210\/en.2011-1254","article-title":"Chronic central leptin decreases food intake and improves glucose tolerance in diet-induced obese mice independent of hypothalamic malonyl CoA levels and skeletal muscle insulin sensitivity","volume":"152","author":"Keung","year":"2011","journal-title":"Endocrinology"},{"key":"2020071611542428900_B148","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1152\/ajpendo.00095.2011","article-title":"Effects of high-fat overfeeding on mitochondrial function, glucose and fat metabolism, and adipokine levels in low birth weight subjects","volume":"302","author":"Br\u00f8ns","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611542428900_B149","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B150","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1210\/en.2011-0185","article-title":"Acute disruption of leptin signaling in vivo leads to increased insulin levels and insulin resistance","volume":"152","author":"Levi","year":"2011","journal-title":"Endocrinology"},{"key":"2020071611542428900_B151","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbadis.2004.11.006","article-title":"Transgenic mice overexpressing SREBP-1a under the control of the PEPCK promoter exhibit insulin resistance, but not diabetes","volume":"1740","author":"Takahashi","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"2020071611542428900_B152","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2337\/diabetes.50.8.1813","article-title":"Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein","volume":"50","author":"Slosberg","year":"2001","journal-title":"Diabetes"},{"key":"2020071611542428900_B153","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.ijo.0801807","article-title":"Influence of leptin and insulin on lipid transfer proteins in human hepatoma cell line, HepG2","volume":"25","author":"Kaser","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071611542428900_B154","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cellbi.2005.03.008","article-title":"Intracellular signal transduction pathways induced by leptin in C2C12 cells","volume":"29","author":"Maroni","year":"2005","journal-title":"Cell Biol Int"},{"key":"2020071611542428900_B155","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1073\/pnas.050580497","article-title":"Selective interaction between leptin and insulin signaling pathways in a hepatic cell line","volume":"97","author":"Szanto","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B156","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MCG.0b013e3181ec5c66","article-title":"The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature","volume":"45","author":"Polyzos","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"2020071611542428900_B157","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1748-1716.2007.01782.x","article-title":"SOCS proteins causing trouble in insulin action","volume":"192","author":"Lebrun","year":"2008","journal-title":"Acta Physiol"},{"key":"2020071611542428900_B158","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/MCB.25.4.1569-1575.2005","article-title":"Activation of SOCS-3 by resistin","volume":"25","author":"Steppan","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2020071611542428900_B159","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3748\/wjg.v8.i3.531","article-title":"The role of endotoxin, TNF-\u03b1, and IL-6 in inducing the state of growth hormone insensitivity","volume":"8","author":"Wang","year":"2002","journal-title":"World J Gastroenterol"},{"key":"2020071611542428900_B160","doi-asserted-by":"crossref","first-page":"13740","DOI":"10.1074\/jbc.M210689200","article-title":"Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes","volume":"278","author":"Senn","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071611542428900_B161","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/rp.59.1.305","article-title":"Leptin signaling in the central nervous system and the periphery","volume":"59","author":"Bj\u00f8rbaek","year":"2004","journal-title":"Recent Prog Horm Res"},{"key":"2020071611542428900_B162","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cmet.2012.01.002","article-title":"Challenges and opportunities of defining clinical leptin resistance","volume":"15","author":"Myers","year":"2012","journal-title":"Cell Metab"},{"key":"2020071611542428900_B163","doi-asserted-by":"crossref","first-page":"13624","DOI":"10.1073\/pnas.0405499101","article-title":"Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice","volume":"101","author":"Lee","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B164","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1074\/jbc.M008553200","article-title":"Liporegulation in diet-induced obesity: the antisteatotic role of hyperleptinemia","volume":"276","author":"Lee","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071611542428900_B165","doi-asserted-by":"crossref","first-page":"E394","DOI":"10.1152\/ajpendo.90914.2008","article-title":"Leptin and insulin resistance: good, bad, or still unclear?","volume":"296","author":"Oral","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611542428900_B166","doi-asserted-by":"crossref","first-page":"E1401","DOI":"10.1152\/ajpendo.90450.2008","article-title":"Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients","volume":"295","author":"Paz-Filho","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611542428900_B167","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.0000165683.09053.02","article-title":"Hyperleptinemia protecting the heart from lipid overload","volume":"45","author":"Unger","year":"2005","journal-title":"Hypertension"},{"issue":"Pt 1","key":"2020071611542428900_B168","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/bj3480055","article-title":"Identification and expression analysis of leptin-regulated immediate early response and late target genes","volume":"348","author":"Waelput","year":"2000","journal-title":"Biochem J"},{"key":"2020071611542428900_B169","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1097-2765(00)80062-3","article-title":"Identification of SOCS-3 as a potential mediator of central leptin resistance","volume":"1","author":"Bj\u00f8rbaek","year":"1998","journal-title":"Mol Cell"},{"key":"2020071611542428900_B170","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1210\/me.2004-0353","article-title":"Feedback inhibition of leptin receptor\/Jak2 signaling via Tyr(1138) of the leptin receptor and suppressor of cytokine signaling 3","volume":"19","author":"Dunn","year":"2005","journal-title":"Mol Endocrinol"},{"key":"2020071611542428900_B171","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-5793(00)02205-5","article-title":"Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor","volume":"486","author":"Eyckerman","year":"2000","journal-title":"FEBS Lett"},{"key":"2020071611542428900_B172","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1210\/en.2004-0726","article-title":"Region-specific leptin resistance within the hypothalamus of diet-induced obese mice","volume":"145","author":"M\u00fcnzberg","year":"2004","journal-title":"Endocrinology"},{"key":"2020071611542428900_B173","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI30688","article-title":"Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function","volume":"117","author":"Bj\u00f6rnholm","year":"2007","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B174","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/en.2006-0672","article-title":"Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age","volume":"148","author":"Morrison","year":"2007","journal-title":"Endocrinology"},{"key":"2020071611542428900_B175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2005.07.004","article-title":"Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice","volume":"2","author":"Ren","year":"2005","journal-title":"Cell Metab"},{"key":"2020071611542428900_B176","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1074\/jbc.M800061200","article-title":"Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo","volume":"283","author":"Zabolotny","year":"2008","journal-title":"J Biol Chem"},{"key":"2020071611542428900_B177","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1517\/14728222.10.1.135","article-title":"Shp2 as a therapeutic target for leptin resistance and obesity","volume":"10","author":"Feng","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"2020071611542428900_B178","doi-asserted-by":"crossref","first-page":"16064","DOI":"10.1073\/pnas.0405041101","article-title":"Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B179","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0196-9781(96)00025-3","article-title":"Leptin enters the brain by a saturable system independent of insulin","volume":"17","author":"Banks","year":"1996","journal-title":"Peptides"},{"key":"2020071611542428900_B180","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI9842","article-title":"Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity","volume":"105","author":"El-Haschimi","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B181","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/endo.143.3.8669","article-title":"Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity","volume":"143","author":"Hileman","year":"2002","journal-title":"Endocrinology"},{"key":"2020071611542428900_B182","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.tem.2006.09.006","article-title":"Development of leptin antagonists and their potential use in experimental biology and medicine","volume":"17","author":"Gertler","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"2020071611542428900_B183","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2008.12.004","article-title":"Endoplasmic reticulum stress plays a central role in development of leptin resistance","volume":"9","author":"Ozcan","year":"2009","journal-title":"Cell Metab"},{"key":"2020071611542428900_B184","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"key":"2020071611542428900_B185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2008.07.043","article-title":"Hypothalamic IKK\u03b2\/NF-\u03baB and ER stress link overnutrition to energy imbalance and obesity","volume":"135","author":"Zhang","year":"2008","journal-title":"Cell"},{"key":"2020071611542428900_B186","doi-asserted-by":"crossref","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3202-10.2010","article-title":"Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity","volume":"30","author":"Koch","year":"2010","journal-title":"J Neurosci"},{"key":"2020071611542428900_B187","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.271.5251.994","article-title":"Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor","volume":"271","author":"Chua","year":"1996","journal-title":"Science"},{"key":"2020071611542428900_B188","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature"},{"key":"2020071611542428900_B189","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35102112","article-title":"Partial leptin deficiency and human adiposity","volume":"414","author":"Farooqi","year":"2001","journal-title":"Nature"},{"key":"2020071611542428900_B190","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B191","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.0308767101","article-title":"Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults","volume":"101","author":"Licinio","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B192","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","article-title":"Effects of recombinant leptin therapy in a child with congenital leptin deficiency","volume":"341","author":"Farooqi","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071611542428900_B193","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1210\/jc.2004-0376","article-title":"Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy","volume":"89","author":"Gibson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B194","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1590\/S0004-27302010000800005","article-title":"Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy","volume":"54","author":"Paz-Filho","year":"2010","journal-title":"Arq Bras Endocrinol Metab"},{"key":"2020071611542428900_B195","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/17477166.2011.608431","article-title":"Leptin deficiency and leptin gene mutations in obese children from Pakistan","author":"Fatima","year":"2011","journal-title":"Int J Pediatr Obes"},{"key":"2020071611542428900_B196","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ng0398-213","article-title":"A leptin missense mutation associated with hypogonadism and morbid obesity","volume":"18","author":"Strobel","year":"1998","journal-title":"Nat Genet"},{"key":"2020071611542428900_B197","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1210\/jcem.86.7.7644","article-title":"Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans","volume":"86","author":"Mantzoros","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B198","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-0028-1082048","article-title":"Deconvolution of insulin secretion, insulin hepatic extraction post-hepatic delivery rates and sensitivity during 24-hour standardized meals: time course of glucose homeostasis in leptin replacement treatment","volume":"41","author":"Andreev","year":"2009","journal-title":"Horm Metab Res"},{"key":"2020071611542428900_B199","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/32911","article-title":"A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction","volume":"392","author":"Cl\u00e9ment","year":"1998","journal-title":"Nature"},{"key":"2020071611542428900_B200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJMoa063988","article-title":"Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor","volume":"356","author":"Farooqi","year":"2007","journal-title":"N Engl J Med"},{"key":"2020071611542428900_B201","first-page":"1206","article-title":"Animal models of diabetes and obesity, including the PBB\/Ld mouse","volume":"35","author":"Hunt","year":"1976","journal-title":"Fed Proc"},{"key":"2020071611542428900_B202","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1210\/en.2004-0219","article-title":"Genetic background (C57BL\/6J versus FVB\/N) strongly influences the severity of diabetes and insulin resistance in ob\/ob mice","volume":"145","author":"Haluzik","year":"2004","journal-title":"Endocrinology"},{"key":"2020071611542428900_B203","first-page":"1","article-title":"W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?","volume":"29","author":"Mantzoros","year":"2010","journal-title":"Endocr Pract"},{"key":"2020071611542428900_B204","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","article-title":"Lipodystrophy: pathophysiology and advances in treatment","volume":"7","author":"Fiorenza","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2020071611542428900_B205","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbalip.2008.12.014","article-title":"Lipodystrophies: disorders of adipose tissue biology","volume":"1791","author":"Garg","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2020071611542428900_B206","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11883-000-0077-1","article-title":"Mouse models of lipodystrophy","volume":"2","author":"Reue","year":"2000","journal-title":"Curr Atheroscler Rep"},{"key":"2020071611542428900_B207","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"2020071611542428900_B208","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI200419511","article-title":"Site and mechanism of leptin action in a rodent form of congenital lipodystrophy","volume":"113","author":"Asilmaz","year":"2004","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B209","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/35002663","article-title":"Leptin and diabetes in lipoatrophic mice","volume":"403","author":"Gavrilova","year":"2000","journal-title":"Nature"},{"key":"2020071611542428900_B210","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2337\/diabetes.50.6.1440","article-title":"Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes","volume":"50","author":"Ebihara","year":"2001","journal-title":"Diabetes"},{"key":"2020071611542428900_B211","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4158\/EP09154.RA","article-title":"Clinical classification and treatment of congenital and acquired lipodystrophy","volume":"16","author":"Chan","year":"2010","journal-title":"Endocr Pract"},{"key":"2020071611542428900_B212","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/cmi.2010.75","article-title":"Leptin in immuno-rheumatological diseases","volume":"8","author":"Vadacca","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"2020071611542428900_B213","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"2020071611542428900_B214","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJM200408053510623","article-title":"Long-term leptin-replacement therapy for lipoatrophic diabetes","volume":"351","author":"Ebihara","year":"2004","journal-title":"N Engl J Med"},{"key":"2020071611542428900_B216","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","article-title":"Long-term efficacy of leptin replacement in patients with generalized lipodystrophy","volume":"54","author":"Javor","year":"2005","journal-title":"Diabetes"},{"key":"2020071611542428900_B217","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/diabetes.51.5.1356","article-title":"Leptin accelerates autoimmune diabetes in female NOD mice","volume":"51","author":"Matarese","year":"2002","journal-title":"Diabetes"},{"key":"2020071611542428900_B218","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","article-title":"Efficacy of leptin therapy in the different forms of human lipodystrophy","volume":"53","author":"Chong","year":"2010","journal-title":"Diabetologia"},{"key":"2020071611542428900_B219","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","article-title":"Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy","volume":"92","author":"Ebihara","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B220","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4158\/EP09155.RA","article-title":"Rationale for leptin-replacement therapy for severe lipodystrophy","volume":"16","author":"Oral","year":"2010","journal-title":"Endocr Pract"},{"key":"2020071611542428900_B221","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4158\/EP11229.OR","article-title":"Clinical effects of long-term metreleptin treatment in patients with lipodystrophy","volume":"17","author":"Chan","year":"2011","journal-title":"Endocr Pract"},{"key":"2020071611542428900_B222","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B223","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jc.2011-2229","article-title":"Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety","volume":"97","author":"Simha","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B224","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jc.2002-021704","article-title":"Human immunodeficiency virus\/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies","volume":"88","author":"Leow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B225","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1086\/430379","article-title":"Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women","volume":"40","author":"Jacobson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020071611542428900_B226","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.metabol.2010.09.011","article-title":"Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment","volume":"60","author":"Magkos","year":"2011","journal-title":"Metab Clin Exp"},{"key":"2020071611542428900_B227","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/sti.79.2.137","article-title":"A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals","volume":"79","author":"Power","year":"2003","journal-title":"Sex Transm Infect"},{"key":"2020071611542428900_B228","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"2020071611542428900_B229","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EJE-08-0597","article-title":"r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans","volume":"160","author":"Brennan","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2020071611542428900_B230","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0026-0495(97)90258-4","article-title":"Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity","volume":"46","author":"Yarasheski","year":"1997","journal-title":"Metab Clin Exp"},{"key":"2020071611542428900_B231","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020071611542428900_B232","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy","volume":"88","author":"Addy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B233","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/jc.2005-1545","article-title":"Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy","volume":"91","author":"Lee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B234","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia","volume":"94","author":"Mulligan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B235","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","article-title":"Metformin in the treatment of HIV lipodystrophy syndrome: a randomized controlled trial","volume":"284","author":"Hadigan","year":"2000","journal-title":"JAMA"},{"key":"2020071611542428900_B236","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial","volume":"140","author":"Hadigan","year":"2004","journal-title":"Ann Intern Med"},{"key":"2020071611542428900_B237","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.metabol.2012.03.013","article-title":"Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome","volume":"61","author":"Sekhar","year":"2012","journal-title":"Metabolism"},{"key":"2020071611542428900_B238","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1056\/NEJMoa072375","article-title":"Metabolic effects of a growth hormone-releasing factor in patients with HIV","volume":"357","author":"Falutz","year":"2007","journal-title":"N Engl J Med"},{"key":"2020071611542428900_B239","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1210\/jc.2010-0490","article-title":"Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data","volume":"95","author":"Falutz","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B240","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1210\/jc.2002-021600","article-title":"Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices","volume":"88","author":"Tong","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B241","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200307040-00011","article-title":"Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy","volume":"17","author":"Vigouroux","year":"2003","journal-title":"AIDS"},{"key":"2020071611542428900_B242","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00126334-200212150-00009","article-title":"Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution","volume":"31","author":"Mynarcik","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020071611542428900_B243","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10284150400009998","article-title":"Adiponectin: novelties in metabolism and hormonal regulation","volume":"7","author":"Duntas","year":"2004","journal-title":"Nutr Neurosci"},{"key":"2020071611542428900_B244","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"2020071611542428900_B245","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/427697","article-title":"Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2 \u00d7 2 factorial, randomized, double-blinded, placebo-controlled trial","volume":"40","author":"Gavrila","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020071611542428900_B246","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.metabol.2010.10.002","article-title":"Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study","volume":"60","author":"Magkos","year":"2011","journal-title":"Metab Clin Exp"},{"key":"2020071611542428900_B247","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1073\/pnas.1015674108","article-title":"Leptin is an effective treatment for hypothalamic amenorrhea","volume":"108","author":"Chou","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B248","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.metabol.2011.05.016","article-title":"Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women","volume":"60","author":"Sienkiewicz","year":"2011","journal-title":"Metabolism"},{"key":"2020071611542428900_B249","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa040388","article-title":"Recombinant human leptin in women with hypothalamic amenorrhea","volume":"351","author":"Welt","year":"2004","journal-title":"N Engl J Med"},{"key":"2020071611542428900_B250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/153537020322800103","article-title":"Leptin-induced changes in body composition in high fat-fed mice","volume":"228","author":"Harris","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"2020071611542428900_B251","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1152\/ajpendo.2000.278.3.E563","article-title":"Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia","volume":"278","author":"Buettner","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611542428900_B252","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1152\/ajpregu.2001.281.1.R115","article-title":"Metabolic responses to leptin in obese db\/db mice are strain dependent","volume":"281","author":"Harris","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2020071611542428900_B253","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2337\/diab.47.2.230","article-title":"Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptide Y and circulating corticosterone concentrations","volume":"47","author":"Mantzoros","year":"1998","journal-title":"Diabetes"},{"key":"2020071611542428900_B254","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1210\/jcem.85.11.6955","article-title":"Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men","volume":"85","author":"Hukshorn","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/rp.59.1.225","article-title":"Leptin and the cardiovascular system","volume":"59","author":"Rahmouni","year":"2004","journal-title":"Recent Prog Horm Res"},{"key":"2020071611542428900_B256","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.ijo.0801952","article-title":"The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects","volume":"26","author":"Hukshorn","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071611542428900_B257","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1463-1326.2005.00468.x","article-title":"Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial","volume":"7","author":"Zelissen","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"2020071611542428900_B258","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-term persistence of hormonal adaptations to weight loss","author":"Sumithran","year":"2011","journal-title":"N Engl J Med"},{"key":"2020071611542428900_B259","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1172\/JCI25977","article-title":"Low dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight","volume":"115","author":"Rosenbaum","year":"2005","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B260","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/382250a0","article-title":"Role of leptin in the neuroendocrine response to fasting","volume":"382","author":"Ahima","year":"1996","journal-title":"Nature"},{"key":"2020071611542428900_B261","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI200317490","article-title":"The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men","volume":"111","author":"Chan","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071611542428900_B262","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1210\/jcem.87.5.8628","article-title":"Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones","volume":"87","author":"Rosenbaum","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B263","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1007\/s00125-011-2201-x","article-title":"Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans","volume":"54","author":"Aronis","year":"2011","journal-title":"Diabetologia"},{"key":"2020071611542428900_B264","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071611542428900_B265","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/eje.0.1380501","article-title":"Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index","volume":"138","author":"Kiess","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2020071611542428900_B266","first-page":"1482","article-title":"Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin","volume":"274","author":"Havel","year":"1998","journal-title":"Am J Physiol"},{"key":"2020071611542428900_B267","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diabetes.48.7.1487","article-title":"Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat","volume":"48","author":"Chinookoswong","year":"1999","journal-title":"Diabetes"},{"key":"2020071611542428900_B268","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2265.2006.02684.x","article-title":"Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans","volume":"66","author":"Chan","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542428900_B269","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1152\/ajpendo.00489.2001","article-title":"Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats","volume":"282","author":"Lin","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611542428900_B270","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1096\/fj.01-0164com","article-title":"Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats","volume":"16","author":"Hidaka","year":"2002","journal-title":"FASEB J"},{"key":"2020071611542428900_B271","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1210\/en.2010-0890","article-title":"Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia","volume":"152","author":"German","year":"2011","journal-title":"Endocrinology"},{"key":"2020071611542428900_B272","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/db10-0958","article-title":"Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling","volume":"60","author":"Denroche","year":"2011","journal-title":"Diabetes"},{"key":"2020071611542428900_B273","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/db09-1918","article-title":"Leptin deficiency causes insulin resistance induced by uncontrolled diabetes","volume":"59","author":"German","year":"2010","journal-title":"Diabetes"},{"key":"2020071611542428900_B274","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/db10-1795","article-title":"Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice","volume":"60","author":"Naito","year":"2011","journal-title":"Diabetes"},{"key":"2020071611542428900_B275","first-page":"61","article-title":"Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease","volume":"121","author":"Saryusz-Wolska","year":"2011","journal-title":"Pol Arch Med Wewn"},{"key":"2020071611542428900_B276","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jc.2007-1856","article-title":"Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy","volume":"93","author":"Park","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542428900_B277","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1399-5448.2011.00797.x","article-title":"Leptin for type 1 diabetes: coming onto stage to be (or not?)","volume":"13","author":"Oral","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"2020071611542428900_B278","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1210\/en.2005-0087","article-title":"Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes","volume":"146","author":"Toyoshima","year":"2005","journal-title":"Endocrinology"},{"key":"2020071611542428900_B279","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00125-009-1258-2","article-title":"Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet","volume":"52","author":"Kusakabe","year":"2009","journal-title":"Diabetologia"},{"key":"2020071611542428900_B280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1381612013398310","article-title":"Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity","volume":"7","author":"Banks","year":"2001","journal-title":"Curr Pharm Design"},{"key":"2020071611542428900_B281","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.2337\/db10-1302","article-title":"Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes","volume":"60","author":"Mittendorfer","year":"2011","journal-title":"Diabetes"},{"key":"2020071611542428900_B282","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/oby.2009.187","article-title":"Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats","volume":"18","author":"Trevaskis","year":"2010","journal-title":"Obesity"},{"key":"2020071611542428900_B283","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","article-title":"Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy","volume":"17","author":"Ravussin","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"2020071611542428900_B284","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/dc07-2433","article-title":"Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide: interventional studies in humans","volume":"31","author":"Hwang","year":"2008","journal-title":"Diabetes Care"},{"key":"2020071611542428900_B285","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nature01388","article-title":"STAT3 signalling is required for leptin regulation of energy balance but not reproduction","volume":"421","author":"Bates","year":"2003","journal-title":"Nature"},{"key":"2020071611542428900_B286","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cmet.2005.10.009","article-title":"Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons","volume":"2","author":"Morton","year":"2005","journal-title":"Cell Metab"},{"key":"2020071611542428900_B287","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"2020071611542428900_B288","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"key":"2020071611542428900_B289","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.23046","article-title":"Adipokines in liver diseases","volume":"50","author":"Marra","year":"2009","journal-title":"Hepatology"},{"key":"2020071611542428900_B290","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hepres.2005.09.024","article-title":"The role of leptin in progression of non-alcoholic fatty liver disease","volume":"33","author":"Ikejima","year":"2005","journal-title":"Hepatol Res"},{"key":"2020071611542428900_B291","doi-asserted-by":"crossref","first-page":"s858","DOI":"10.1093\/ajcn\/86.3.858S","article-title":"Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence","volume":"86","author":"Barb","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"2020071611542428900_B292","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2119\/molmed.2011.00243","article-title":"p38 mitogen-activated protein kinase and liver X receptor-\u03b1 mediate the leptin effect on sterol regulatory element binding protein-1c expression in hepatic stellate cells","volume":"18","author":"Yan","year":"2012","journal-title":"Mol Med"},{"key":"2020071611542428900_B293","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1074\/jbc.M308351200","article-title":"Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells","volume":"279","author":"Cao","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071611542428900_B294","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jhep.2006.07.027","article-title":"Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells","volume":"46","author":"Cao","year":"2007","journal-title":"J Hepatol"},{"key":"2020071611542428900_B295","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/hep.22560","article-title":"Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells","volume":"48","author":"De Minicis","year":"2008","journal-title":"Hepatology"},{"key":"2020071611542428900_B296","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1440-1746.2007.04961.x","article-title":"Role of adipocytokines in hepatic fibrogenesis","volume":"22","author":"Ikejima","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"2020071611542428900_B297","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10552-010-9573-y","article-title":"B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in Greece","volume":"21","author":"Dalamaga","year":"2010","journal-title":"Cancer Causes Control"},{"key":"2020071611542428900_B298","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/bbrc.1997.8193","article-title":"Transdifferentiation of rat hepatic stellate cells results in leptin expression","volume":"244","author":"Potter","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071611542428900_B299","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.gastro.2009.04.011","article-title":"Kupffer cells mediate leptin-induced liver fibrosis","volume":"137","author":"Wang","year":"2009","journal-title":"Gastroenterology"},{"key":"2020071611542428900_B300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","article-title":"Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling","volume":"16","author":"Imajo","year":"2012","journal-title":"Cell Metab"},{"key":"2020071611542428900_B301","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3748\/wjg.14.2888","article-title":"Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease","volume":"14","author":"Huang","year":"2008","journal-title":"W J Gastroenterol"},{"key":"2020071611542428900_B302","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cgh.2006.06.011","article-title":"Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease","volume":"4","author":"Wong","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020071611542428900_B303","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.34738","article-title":"Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?","volume":"36","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"2020071611542428900_B304","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1665-2681(19)31790-9","article-title":"Adipokines in a group of mexican patients with nonalcoholic steatohepatitis","volume":"8","author":"Mu\u00f1oz","year":"2009","journal-title":"Ann Hepatol"},{"key":"2020071611542428900_B305","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s11695-009-9912-9","article-title":"Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery","volume":"19","author":"Argentou","year":"2009","journal-title":"Obes Surg"},{"key":"2020071611542428900_B306","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1111\/j.1572-0241.2003.08767.x","article-title":"Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?","volume":"98","author":"Chalasani","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2020071611542428900_B307","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jhep.2004.08.020","article-title":"Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease","volume":"41","author":"Angulo","year":"2004","journal-title":"J Hepatol"},{"key":"2020071611542428900_B308","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/eje.1.02288","article-title":"Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease","volume":"155","author":"Nobili","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2020071611542428900_B309","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/oby.2010.95","article-title":"Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease","volume":"18","author":"Medici","year":"2012","journal-title":"Obesity"},{"key":"2020071611542428900_B310","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","article-title":"Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"key":"2020071611542428900_B311","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2011.12.011","article-title":"Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up","author":"Zelber-Sagi","year":"2012","journal-title":"J Hepatol"},{"key":"2020071611542428900_B312","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2006.05.005","article-title":"Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement","volume":"4","author":"Lutchman","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020071611542428900_B313","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.metabol.2008.07.030","article-title":"Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia","volume":"57","author":"Hyogo","year":"2008","journal-title":"Metabolism"},{"key":"2020071611542428900_B314","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00535-010-0291-8","article-title":"Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease","volume":"46","author":"Park","year":"2011","journal-title":"J Gastroenterol"},{"key":"2020071611542428900_B315","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1365-2036.2011.04626.x","article-title":"Enteric-coated cysteamine for the treatment of paediatric non[b]-alcoholic fatty liver disease","volume":"33","author":"Dohil","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"2020071611542428900_B316","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1478-3231.2009.02037.x","article-title":"Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis","volume":"29","author":"Balmer","year":"2009","journal-title":"Liver Int"},{"key":"2020071611542428900_B317","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-079X.2012.01023.x","article-title":"Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin","volume":"54","author":"Gonciarz","year":"2013","journal-title":"J Pineal Res"},{"key":"2020071611542428900_B318","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0030-1247348","article-title":"[Obesity as a risk factor for prostate cancer: role for adipocytokines and involvement of tyrosine kinase pathway]","volume":"41","author":"Hoda","year":"2010","journal-title":"Aktuelle Urol"},{"key":"2020071611542428900_B319","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/annonc\/mdm464","article-title":"Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study","volume":"19","author":"Gogas","year":"2008","journal-title":"Ann Oncol"},{"key":"2020071611542428900_B320","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2010.07.007","article-title":"Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects","volume":"119","author":"Ashizawa","year":"2010","journal-title":"Gynecol Oncol"},{"key":"2020071611542428900_B321","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.biochi.2012.06.013","article-title":"The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis","volume":"94","author":"Grossmann","year":"2012","journal-title":"Biochimie"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/34\/3\/377\/10335358\/edrv0377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/34\/3\/377\/10335358\/edrv0377.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T10:46:43Z","timestamp":1715424403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/34\/3\/377\/2354640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,1]]},"references-count":321,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2012-1053","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,1]]}}}